Toru Wakamatsu

Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment

Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka et al. · Investigational New Drugs · 2017 · 66 citations

Second-line Treatment, Hepatology, Medicine +8

Changes in cell migration of mesenchymal cells during osteogenic differentiation

Masanori Ichida, Yoshihiro Yui, Kiyoko Yoshioka et al. · FEBS Letters · 2011 · 49 citations

Bone Repair, Stem Cell Migration, Cellular Physiology +16

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma

Masayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen et al. · Oncotarget · 2017 · 47 citations · Full text

Histone Modifications, Histone H3, Epigenetic Change +23

Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma

Yoshinori Imura, Hirohiko Yasui, Hidetatsu Outani et al. · Molecular Cancer · 2014 · 46 citations · Full text

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy

Takaaki Tanaka, Yoshihiro Yui, Norifumi Naka et al. · Clinical & Experimental Metastasis · 2012 · 41 citations · Full text